Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

32.69 +0.35 (+1.09%)

Streaming Delayed Price Updated: 3:14 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

48 49 Next >

What's going on in today's pre-market session ↗

February 25, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

February 25, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Via StockStory

Markets Mostly Dip Red Late In Regular Trading ↗

February 24, 2025

Market indexes drooped in the final minutes of the normal trading day to start a new week, with all major indexes save the blue-chip Dow closing in the red, adding to Friday’s losses.

Via Talk Markets

Topics Stocks Stocks / Equities

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

Smart Money Is Betting Big In HIMS Options ↗

February 24, 2025

Via Benzinga

Why Hims & Hers Health Stock Is Plummeting Today ↗

February 21, 2025

Via The Motley Fool

Why Novo Nordisk Stock Popped on Friday ↗

February 21, 2025

Via The Motley Fool

What's going on in today's after hours session ↗

February 24, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat ↗

February 24, 2025

Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter.

Via Benzinga

Hims & Hers Health (NYSE:HIMS) Beats Q4 Sales Targets But Stock Drops 16%

February 24, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue...

Via StockStory

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

February 24, 2025

From Hims & Hers

Via Business Wire

Why the growth investor may take a look at NYSE:HIMS. ↗

February 21, 2025

A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations

Via Chartmill

Why Hims & Hers Stock Dropped Today ↗

February 20, 2025

Via The Motley Fool

What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle ↗

February 24, 2025

Hims & Hers Health is on deck to report its fourth-quarter earnings late Monday. Here's what to expect.

Via Investor's Business Daily

Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday? ↗

February 24, 2025

The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.

Via Benzinga

Topics Stocks

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗

February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Via Stocktwits

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.

Via StockStory

Market Whales and Their Recent Bets on HIMS Options ↗

February 20, 2025

Via Benzinga

Earnings Scheduled For February 24, 2025 ↗

February 24, 2025

Via Benzinga

MarketBeat Week in Review – 02/17 - 02/21

February 22, 2025

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news

Via MarketBeat

Topics Economy

Don't Call It A Stock Market Crash ↗

February 21, 2025

A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way.

Via Talk Markets

Topics ETFs Stocks / Equities

Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session. ↗

February 21, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today

February 21, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug Administration (FDA) reported that the shortage of weight-loss drugs such as...

Via StockStory

Topics Artificial Intelligence

Top movers in Friday's session ↗

February 21, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Stocks Firmly Lower As Consumer Sentiment Weakens ↗

February 21, 2025

The Dow Jones Industrial Average is headed for another sharp triple-digit drop to end the week.

Via Talk Markets

Topics Stocks Stocks / Equities

What's Going On With Hims & Hers Health Stock Today? ↗

February 21, 2025

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized treatments. Also, in another development, FDA resolves semaglutide injection...

Via Benzinga

Topics Economy

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage ↗

February 21, 2025

The FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved.

Via Investor's Business Daily

Hims & Hers Acquires US-based Peptide Facility

February 21, 2025

From Hims & Hers

Via Business Wire

Buy HIMS Stock Here ↗

February 19, 2025

In this video, I provide my technical analysis for how I would manage the risk and book the profits on the trade.

Via Talk Markets

Topics Stocks / Equities

Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided ↗

February 19, 2025

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.

Via Stocktwits

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.